UTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 427.4 EUR Market Closed

Market Cap: €12B

U	United Therapeutics Corp XBER:UTH	US
	Meituan F:9MDA	CN
L	Liberty Broadband Corp NASDAQ:LBRDK	US
F	Ferrari NV F:2FE	IT
V	Verisign Inc DUS:VRS	US
	GMO Media Inc TSE:6180	JP
S	Sumitomo Osaka Cement Co Ltd F:SU2	JP
D	Dermapharm Holding SE XBER:DMP	DE

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

90% > 87%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

49%

Declining Operating Margin

52% > 45%

Exceptional Net Margin

41%

Strong 3Y Average Net Margin

41%

Declining Net Margin

41% > 41%

Exceptional Free Cash Flow Margin

32%

Strong 3Y Average Free Cash Flow Margin

34%

Declining Free Cash Flow Margin

32% > 32%

Positive ROE

20%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

28%

ROIC is Increasing

25% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.